LivaNova PLC - Ordinary Shares (LIVN): Price and Financial Metrics


LivaNova PLC - Ordinary Shares (LIVN): $56.16

0.79 (+1.43%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

LIVN POWR Grades

  • Growth is the dimension where LIVN ranks best; there it ranks ahead of 99.73% of US stocks.
  • LIVN's strongest trending metric is Growth; it's been moving up over the last 179 days.
  • LIVN's current lowest rank is in the Momentum metric (where it is better than 35.42% of US stocks).

LIVN Stock Summary

  • The price/operating cash flow metric for LIVANOVA PLC is higher than 85.59% of stocks in our set with a positive cash flow.
  • With a year-over-year growth in debt of 104.93%, LIVANOVA PLC's debt growth rate surpasses 88.25% of about US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, LIVANOVA PLC is reporting a growth rate of -86.89%; that's higher than only 16.42% of US stocks.
  • If you're looking for stocks that are quantitatively similar to LIVANOVA PLC, a group of peers worth examining would be EVCM, SANW, CEMI, ANGO, and TRUE.
  • Visit LIVN's SEC page to see the company's official filings. To visit the company's web site, go to www.livanova.com.

LIVN Valuation Summary

  • LIVN's price/earnings ratio is -29.8; this is 228.45% lower than that of the median Healthcare stock.
  • Over the past 86 months, LIVN's price/earnings ratio has gone down 102.8.

Below are key valuation metrics over time for LIVN.

Stock Date P/S P/B P/E EV/EBIT
LIVN 2022-11-25 2.8 2.5 -29.8 -62.7
LIVN 2022-11-23 2.8 2.5 -29.8 -62.8
LIVN 2022-11-22 2.8 2.5 -29.7 -62.7
LIVN 2022-11-21 2.8 2.5 -29.2 -61.6
LIVN 2022-11-18 2.8 2.5 -29.4 -62.0
LIVN 2022-11-17 2.7 2.4 -28.9 -61.0

LIVN Growth Metrics

    Its year over year net income to common stockholders growth rate is now at 74.99%.
  • Its 3 year net income to common stockholders growth rate is now at 52.59%.
  • Its 2 year revenue growth rate is now at -4.45%.
LIVN's revenue has moved down $67,175,000 over the prior 33 months.

The table below shows LIVN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 1,016.995 84.698 -96.472
2022-06-30 1,017.605 73.013 -31.365
2022-03-31 1,027.937 108.887 -103.127
2021-12-31 1,035.365 102.544 -135.818
2021-09-30 1,034.856 106.049 -407.079
2021-06-30 1,021.724 90.753 -379.614

LIVN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • LIVN has a Quality Grade of C, ranking ahead of 45.21% of graded US stocks.
  • LIVN's asset turnover comes in at 0.441 -- ranking 110th of 186 Medical Equipment stocks.
  • XRAY, PDEX, and ZBH are the stocks whose asset turnover ratios are most correlated with LIVN.

The table below shows LIVN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.441 0.662 -0.416
2021-06-30 0.421 0.653 -0.308
2021-03-31 0.383 0.654 -0.262
2020-12-31 0.378 0.662 -0.271
2020-09-30 0.385 0.683 -0.167
2020-06-30 0.397 0.690 -0.156

LIVN Price Target

For more insight on analysts targets of LIVN, see our LIVN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $100.71 Average Broker Recommendation 1.43 (Moderate Buy)

LIVN Stock Price Chart Interactive Chart >

Price chart for LIVN

LIVN Price/Volume Stats

Current price $56.16 52-week high $89.69
Prev. close $55.37 52-week low $41.82
Day low $54.45 Volume 311,209
Day high $57.28 Avg. volume 385,669
50-day MA $49.50 Dividend yield N/A
200-day MA $63.47 Market Cap 3.01B

LivaNova PLC - Ordinary Shares (LIVN) Company Bio


LivaNova PLC. offers cardiac surgery, cardiac rhythm management, and neuromodulation related products worldwide. The company was founded in 1987 and is based in London, England.


LIVN Latest News Stream


Event/Time News Detail
Loading, please wait...

LIVN Latest Social Stream


Loading social stream, please wait...

View Full LIVN Social Stream

Latest LIVN News From Around the Web

Below are the latest news stories about LIVANOVA PLC that investors may wish to consider to help them evaluate LIVN as an investment opportunity.

Should You Think About Buying LivaNova PLC (NASDAQ:LIVN) Now?

LivaNova PLC ( NASDAQ:LIVN ), might not be a large cap stock, but it received a lot of attention from a substantial...

Yahoo | November 24, 2022

LivaNova Receives 510(k) Clearance for ECMO from FDA for LifeSPARC, the Next-generation Advanced Circulatory Support System

LONDON, November 17, 2022--LivaNova PLC today announced it received 510(k) clearance for ECMO from the U.S. FDA for LifeSPARC, a next-generation circulatory support system.

Yahoo | November 17, 2022

LivaNova to Present at the Stifel, Wolfe and Piper Sandler Healthcare Conferences

LONDON, November 08, 2022--LivaNova PLC announced its CEO Damien McDonald will present in fireside chats at three healthcare conferences in New York this month.

Yahoo | November 8, 2022

LivaNova (NASDAQ:LIVN) Is Experiencing Growth In Returns On Capital

There are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like to...

Yahoo | November 7, 2022

Analysts’ Top Healthcare Picks: LivaNova (LIVN), Surface Oncology (SURF)

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on LivaNova (LIVN – Research Report) and Surface Oncology (SURF – Research Report) with bullish sentiments. LivaNova (LIVN) Needham analyst Michael Matson reiterated a Buy rating on LivaNova today and set a price target of $77.00. The company's shares closed last Wednesday at $47.55, close to its 52-week low of $41.82. According to TipRanks.

Howard Kim on TipRanks | November 2, 2022

Read More 'LIVN' Stories Here

LIVN Price Returns

1-mo 20.10%
3-mo 3.25%
6-mo -17.99%
1-year -30.28%
3-year -31.98%
5-year -36.18%
YTD -35.77%
2021 32.05%
2020 -12.22%
2019 -17.54%
2018 14.45%
2017 77.72%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6219 seconds.